Advertisement

Antibody Guided Diagnosis and Therapy of Patients with Breast Cancer

  • Haralambos P. Kalofonos
  • Agemenmon A. Epenetos

Abstract

Tumour associated monoclonal antibodies HHFG1 and HMFG2, labelled with iodine-123, and F(ab’)2 of HMFG1, labelled with indium-Ill, were used to detect primary and metastatic breast cancer, by external body scintigraphy, in 13 patients with measurable disease. Tumours became visible in the majority (9 out of 13) of patients. We detected both primary breast cancer and bony and soft tissue metastases. The presence of antibody in the tumours was confirmed by autoradiography and immunoperoxidase staining of surgically removed tissues. Ill-In labelled F(ab’)2 fragments were superior to whole antibody. We imaged successfully the disease in 5 out of 7 patients, injected with radiolabeled F(ab’)2 °f HMFG1. 2 patients with negative antibody scans had received prior chemotherapy and were in clinical remission.

Tumour associated monoclonal antibodies HHFG1, HMFG2 and AUA1 radiolabeled with iodine-131, were given intracavitary (intrapleurally and intrapericardially) to patients with malignant serous effusions secondary to breast and other epithelial cancers. Ten out of thirteen effusions (3 pericardial and 7 pleural) 1n 11 patients, responded completely with no fluid reaccumulation, between 3 and 18 months. No toxicity was encountered.

We conclude that this new method of treatment is nontoxic and effective, resulting in improved quality of life and in some cases, prolongation of survival of patients with breast or other epithelial origin neoplasms.

Keywords

Breast Cancer Pericardial Effusion Malignant Pleural Effusion Malignant Effusion Medical Internal Radiation Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kohler G. and Milstein C. Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature 256:495–497 (1975).PubMedCrossRefGoogle Scholar
  2. 2.
    Wright G. Application of monoclonal antibodies to the study of human cancer, in: “Monoclonal Antibodies and Cancer,” G.L. Wright, ed., Marcel Dekker, New York, pp 1–31 (1984).Google Scholar
  3. 3.
    Epenetos A.A., Britton K.E., Mather S., et al. Targetting of 123 I-labelled-tumour associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet 2:999–1003 (1982).PubMedCrossRefGoogle Scholar
  4. 4.
    Mach J.P., Buchegger F., Forni M., et al. Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunology Today December, 239–249 (1981).Google Scholar
  5. 5.
    Farrands P.A., Perkins A.C., Pimm M.V. et al. Radioimmunodetection of human colorectal cancer by an anti-tumour monoclonal antibody. Lancet 2:397–400 (1982).PubMedCrossRefGoogle Scholar
  6. 6.
    Larson S.M., Brown J.P., Wright P.W. et al. Imaging of melanoma with I-131-labelled monoclonal antibodies. J. Nucl. Med. 23:123–129 (1983).Google Scholar
  7. 7.
    Baldwin R.W., Pimm V. Antitumour monoclonal antibodies for radioimmunodetection of tumours and drug targeting. Cancer Metastasis Rev. 2:89–106 (1983).PubMedCrossRefGoogle Scholar
  8. 8.
    Thorpe R.E. and Ross W.C. The preparation and cytotoxic properties of antibody-toxin conjugates. Immuno. Rev. 62, 119 (1982).CrossRefGoogle Scholar
  9. 9.
    Order S.E., Klein J.L., Ettinger D. et al. Use of isotopic immunoglobulin in therapy. Cancer Res. 40:3001 (1980).PubMedGoogle Scholar
  10. 10.
    Epenetos A.A., Courtenay-Luck N., Hainan K.E., et al. Antibody guided irradiation of malignant lesions. Lancet 30:1441–1443 (1984).Google Scholar
  11. 11.
    Carrasquilo J.A., Krohn K.A., Beaumier P., et al. Diagnosis of and therapy for solid tumours with radiolabelled antibodies and immune fragments. Cancer Treat. Rep. 68:371–378 (1984).Google Scholar
  12. 12.
    Haskell C.L. Cancer Treatment. Breast Cancer. Ed. C.L. Haskell, W.B. Saunders, pp 137–180 (1985).Google Scholar
  13. 13.
    Fisher B. Laboratory and clinical research in breast cancer. Cancer Res. 40:3863 (1980).PubMedGoogle Scholar
  14. 14.
    Brinkley D., Haybittle J.L. The curability of breast cancer. Lancet ii, 95–97 (1975).CrossRefGoogle Scholar
  15. 15.
    Epenetos A.A., Snook, D., Durbin, H. et al. Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. Cancer Res. 46:3183–3191 (1986).PubMedGoogle Scholar
  16. 16.
    Rainsbury R.M., Ott R.J., Westwood J.H. et al. Location of metastatic breast carcinoma by a monoclonal antibody chelate-labelled with indium-111. Lancet 22:934–938 (1983).CrossRefGoogle Scholar
  17. 17.
    Hayes D.F., Zalutsky M.R., Kaplan W. et al. Pharmacokinetics of radiolabelled monoclonal antibody B6.2 in patients with metastatic breast cancer. Cancer Res. 46:3157–3163 (1986).PubMedGoogle Scholar
  18. 18.
    Order S.E., Klein J., Ettinger D., et al. Phase I-II study of radiolabelled antibody integrated in the treatment of primary hepatic malignancies. Int. J. Rad. Oncol. Biol and Physics 6, 703–710 (1980).CrossRefGoogle Scholar
  19. 19.
    Epenetos A.A., Courtenay-Luck N., Pickering D., et al. Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen. Br. Med. 3. 290, 1463–1466 (1985).CrossRefGoogle Scholar
  20. 20.
    Anderson C., Philpott G. and Ferguson T., et al. The treatment of malignant pleural effusions. Cancer 33:916 (1974).PubMedCrossRefGoogle Scholar
  21. 21.
    Wallach H.W. Intrapleural tetracycline for malignant pleural effusions. Chest 68, 50 (1975).CrossRefGoogle Scholar
  22. 22.
    Paladine W., Cunningham T., Spoyzo R., et al. Intracavity bleomycin in the management of malignant effusions. Cancer 38:1903 (1976).PubMedCrossRefGoogle Scholar
  23. 23.
    Strober S., Kloty E., Kuperman and Gossein N. Malignant pleural disease. A radiotherapeutic approach to the problem. JAMA 226, 296 (1973).PubMedCrossRefGoogle Scholar
  24. 24.
    Osteowski M. and Halsall G. Intracavitary bleomycin in the management of malignant effusions: a multicentre study. Cancer Treat. Rep. 66, 1903 (1982).Google Scholar
  25. 25.
    Epenetos A.A., Canti G., Taylor-Papadimitriou J., et al. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Lancet ii, 1004–1006 (1982).CrossRefGoogle Scholar
  26. 26.
    Arklie J., Taylor-Papadimitriou J., Bodmer W.F., et al. Differentiation antigens expressed by epithelial cells in the lactating breast and also detectable in breast cancers. Int. J. Cancer 28:23–29 (1981).PubMedCrossRefGoogle Scholar
  27. 27.
    Taylor-Papadimitriou J., Peterson J.A., Arklie J., et al. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane. Production and reaction with cells in culture. Int. J. Cancer 28:17–21 (1981).PubMedCrossRefGoogle Scholar
  28. 28.
    Arklie J. Studies of the human epithelian cell surface using monoclonal antibodies. Ph.D. Dissertation, University of Oxford (1981).Google Scholar
  29. 29.
    Epenetos A.A., Nimmon C.C., Arklie J., et al. Detection of human cancer in an animal model using radiolabelled tumour associated monoclonal antibodies. Br. J. Cancer 46:1–6 (1982).PubMedCrossRefGoogle Scholar
  30. 30.
    Fraker P.J. and Speck J.C. Protein and cell membrane iodination with sparingly soluble shloramide, 1,3,4,6-tetrachloro-5, 6-diphenylglycouril. Biochem. Biophys. Res. Commun. 80, 849 (1978).PubMedCrossRefGoogle Scholar
  31. 31.
    Hnatowich D.J., Layne W.W., and Childs R.L. The preparation and labelling of DTPA-coupled albumin. Int. J. Appl. Radio. Isot. 33, 327–332 (1982).CrossRefGoogle Scholar
  32. 32.
    Hnatowich D.J. et al. Radioactive labelling of antibody: a simple and efficient method. Science 220:613–15 (1983).PubMedCrossRefGoogle Scholar
  33. 33.
    Oi V.T., Jones P.P., Goding J.W., et al. Current properties of monoclonal antibodies to mouse Ig allotypes, H-2 and Ia antigens. Curr. Topic. Microbiol. Immunol. 81:115–29 (1979).Google Scholar
  34. 34.
    Snyder W.S., Ford M.R., Warner G.G. Estimates of specific absorbed fractions for photon sources uniformly distributed in various organs of a heterogenous phantom. New York; Society of Nuclear Medicine, 1978:5–67. (Medical Internal Radiation Dose (MIRD) pamphlet 5).Google Scholar
  35. 35.
    Scheinberg D.A., Strand M., Gansow O.A., et al. Tumour imaging with radioactive metal chelates conjugated to monoclonal antibodies. Science 215:1511–1513 (1982).PubMedCrossRefGoogle Scholar
  36. 36.
    Paxton R.J., Jakowatz J.G., Beatty D., et al. High-specific-activity of indium-111 labelled anti-carcinoembryonic antigen monoclonal: improved method for the synthesis of diethylenetriaminopentacetic acid conjugates. Cancer Res. 45:5694–5699 (1985).PubMedGoogle Scholar
  37. 37.
    Epenetos A.A., Hooker G., Durbin H., et al. Indium-lll-labelled, monoclonal antibody to placental alkaline phosphatase in the detection of neoplasms of tesis, ovary and cervix. Lancet i, 350–353 (1985).CrossRefGoogle Scholar
  38. 38.
    Hnatowich D.J., Griffin T.W., Kosciaczyk D., et al. Pharmacokentics of an indium-111-labelled monoclonal antibody in cancer patients. J. Nucl. Med. 26:849–858 (1985).PubMedGoogle Scholar
  39. 39.
    Sakahara H., Endo K., Nakashima T., et al. Effect of DTPA conjugation on the antigen binding activity and biodistribution of monoclonal antibodies against α-fetoprotein. J. Nucl. Med. 26:750–755 (1985).PubMedGoogle Scholar
  40. 40.
    Wahl R.L., Parker C.W., and Philpott G.W., et al. Improved radioimaging and tumour localisation with monoclonal F(ab’)2 fragments. J. Nucl. Med. 24, 316–325 (1983).PubMedGoogle Scholar
  41. 41.
    Fawwaz R.A., Wang T.S.T., Eastbrook K.A., et al. Immunoreactivity and biodistribution of indium-111-labelled monoclonal antibody to human high molecular weight-melanoma associated antigen. J. Nucl. Med. 26:488–492 (1985).PubMedGoogle Scholar
  42. 42.
    Harwood P.O., Boden J., Pedley R.B., et al. Comparative tumour localisation of antibody fragments and intact IgG in nude mice bearing a CEA-producing human colon tumour xenograft. Eur. J. Cancer Clin. Oncology 21, 1512–1522 (1985).Google Scholar
  43. 43.
    Colcher D., Zalutsky M., Kaplan W., et al. Radiolocalization of human mammary tumours in athymic mice by monoclonal antibody. Cancer Res. 43:736–742 (1983).PubMedGoogle Scholar
  44. 44.
    Buchegger F., Haskell C.M., Schreyer M., et al. Radiolabel led fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J. Exp. Med. 158, 413–427 (1983).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Haralambos P. Kalofonos
    • 1
  • Agemenmon A. Epenetos
    • 1
  1. 1.Imperial Cancer Research Fund Oncology Group, Department of Clinical OncologyRoyal Postgraduate Medical School, Hammersmith Hospital and Imperial Cancer Research FundLondonUK

Personalised recommendations